Guidelines for ATC classification and DDD assignment - WHOCC

V09H INFLAMMATION AND INFECTION DETECTION
270
This group comprises agents for the detection of inflammation and
infection. Labelled blood cells are classified in this group. Agents that
are used for the labelling of these cells can also be classified elsewhere,
e.g. technetium-exametazime is classified in V09A -Central Nervous
System. No subdivision is made for the type of labelled cells
(erythrocytes, granulocytes or autologous etc.).
V09HA Technetium ( 99m Tc) compounds
V09HB Indium ( 111 In) compounds
V09HX Other diagnostic radiopharmaceuticals for inflammation and infection
detection
V09I TUMOUR DETECTION
This group comprises monoclonal antibodies and other compounds used
for tumour detection.
V09IA Technetium ( 99m Tc) compounds
V09IB Indium ( 111 In) compounds
V09IX Other diagnostic radiopharmaceuticals for tumour detection
Gallium-citrate used for non-specific tumour localisation is classified in
V09H - Inflammation and infection detection. Thallium-chloride used
for tumour detection is classified in V09G -Cardiovascular system.
Iobenguane ( 131 I) in low dose is classified here while high dose for
therapy is classified in V10X -Other therapeutic radiopharmaceuticals.
V09X OTHER DIAGNOSTIC RADIOPHARMACEUTICALS
This group contains various diagnostic radiopharmaceuticals which
cannot be classified in the preceding groups.
V09XA Iodine ( 131 I) compounds
V09XX Various diagnostic radiopharmaceuticals